Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

10:29 EDT 28th July 2016 | BioPortfolio

Showing News Articles 1–25 of 590,000+

Thursday 28th July 2016

A New Threat in Fight Against Overdoses: Elephant Sedative

NewsA drug used to sedate elephants and other large animals, 100 times as potent as the fentanyl already escalating the country's heroin troubles, is suspected in spates of overdoses in several states

Mosquitoes Suspected in 2 New Mysterious Florida Zika Cases

NewsFlorida health officials are investigating two more mysterious cases of Zika infection that do not appear to be related to travel, bringing the total to four.

Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis

Objective To assess the effect of treatment for cervical intraepithelial neoplasia (CIN) on obstetric outcomes and to correlate this with cone depth and comparison group used.Design Systematic review...

NHS “haemorrhaging money” on clinical negligence claims, defence bodies warn

The NHS paid out £1.5bn (€1.8bn; $2bn) on clinical negligence claims in 2015-16, a rise of 27% from the previous year.The figures, released by the NHS Litigation Authority, showed that the overall...

Pregnancy outcomes after treatment for preinvasive cervical lesions

The anatomy and histological structure of the uterine cervix are mainly responsible for providing the support needed to bring a pregnancy to term. Both characteristics can be significantly altered...

Tribute to Ahilan Kathirgamathamby

On 19 July 2016, Ahilan Kathirgamathamby, beloved son and brother, passed away after an eight year battle with cancer. He was 38 years old. Ahilan worked as a pharmacist for ten years, adoring the people he worked with and the community he served. Throughout his life, he selflessly supported his family, never asking for anything in return.

Deaths: Ahilan Kathirgamathamby

On 19 July 2016, Ahilan Kathirgamathamby MRPharmS, aged 38, of Ilford, Essex. Mr Kathirgamathamby registered with the Society in 2004.

Q&A: New RPS president Martin Astbury

Two years after he was succeeded by Ash Soni, recently affirmed RPS president and self-professed ‘Joe Bloggs pharmacist’ Martin Astbury says he has learnt from his four terms from 2010 to 2014 and is ready to serve the Society again.

Fiberstar, Inc. Launches a Student Innovation Contest using Novel Citrus Fibers

To support University academia and the Food Science communities, Fiberstar initiated a Student innovation contest involving new and novel uses for citrus fiber. This contest not only provides Students experience creating solutions for real world issues, but also, firsthand knowledge in how to formulate using clean and sustainable ingredients like Citri-Fi, a natural citrus fiber. River Falls, Wisc...

ObsEva Initiates Phase 1 Clinical Program of OBE022, a First-in-Class Orally Active Prostaglandin F2alpha Antagonist, for the Treatment of Preterm Labor

ObsEva SA / ObsEva Initiates Phase 1 Clinical Program of OBE022, a First-in-Class Orally Active Prostaglandin F2alpha Antagonist, for the Treatment of Preterm Labor . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. PRESS RELEASE ObsEva Initiates Phase 1 Clinical Program of OBE022, a First-in-Cla...

Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year

  Lower end of revenue guidance increased for FY 2017 DANVERS, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2017 revenue of $103.0 million, an increase of 40% compared to revenue of $73.4 million for the same period of fiscal 2016. First quarter fiscal 2017 GA...

Genetic profiling increases cancer treatment options

Genetic profiling of cancer tumours provides new avenues for treatment of the disease, according to a study conducted by Sanford Health and recognised by the American Society of Clinical Oncology. In 2014, Sanford developed and launched the Genetic...

Sampling Method Used for New Breast Cancer Tests May Lead to Underestimate of Risk, UPCI Finds

Not only is breast cancer more than one disease, but a single breast cancer tumor can vary within itself, giving the potential for very different patient treatment plans depending on the tumor sample and diagnostic testing used. The results demonstrate that tumor sampling techniques used with newly developed “personalized medicine” gene expression profile tests may need to be refined to ensure...

East Los Angeles Dentist, Dr. Ramin Assili, is Now Offering a Promotion on Dental Implants

Dr. Ramin Assili is currently offering a promotion on dental implants, the best way to replace missing teeth. East Los Angeles, CA (PRWEB) July 28, 2016 East LA dentist, Dr. Ramin Assili, announces the new promotion he is offering on dental implants. Patients can currently get a dental implant for $999, not including the restorative implant crown placed on top. This promotion expires September 30...

Medpricer Appoints New Chief Commercial Officer to Accelerate its Growth and Help Healthcare Systems Reduce Costs

Medpricer adds experienced healthcare industry executive as its new Chief Commercial Officer to develop and execute Medpricer’s commercial strategy of helping healthcare systems quickly save money. Guilford, CT (PRWEB) July 28, 2016 Medpricer, healthcare’s leading cost management platform for purchased services, announced that Patrick McCarthy has joined Medpricer as its new Chief Commercial ...

Advances in Gene Editing and Gene Silencing | September 20-21, 2016 | Boston, MA

Advances in Gene Editing and Gene Silencing | September 20-21, 2016 | Boston, MA KEYNOTE SESSION: GENOME EDITING FOR IN VIVO APPLICATIONS Part 1 (of a two-part conference) will cover the use of CRISPR/Cas9 and RNAi for identifying new drug targets and therapies. It will bring together experts from all aspects of basic science and clinical research to […]

NICE finalises record-breaking Opdivo/Yervoy appraisal

BMS’s immunotherapy combination receives recommendation in 24 days

New Model May Help Solve Mystery of How Lithium Stabilizes Moods

NewsThe new model provides a fresh perspective that can sharpen research aimed at pinning down lithium’s biochemical targets.Contributed Auth

FDA Grants Breakthrough Designation to J&J's Darzalex

NewsBreakthrough Therapy Designation was granted to daratumumab based on data from two Phase 3 studies.Topics: 

Inovio Pharma begins dosing patients in phase I study of Zika DNA vaccine, GLS─5700

Inovio Pharmaceuticals, Inc. announced the dosing of the first subject in its multi─center phase I trial to evaluate Inovio's Zika DNA vaccine (GLS─5700).

Maha FDA cancels license of city retail chemist for violation of Rule 65 of D&C Act

Maharashtra Food and Drug Administration (FDA) has cancelled license of a Mumbai based retailer for selling medicines without a pharmacist and also took administrative action in another case for wrong dispensing of hormones and multi─vitamins at the point of sale (POS) in contravention to Rule 65 of Drugs and Cosmetics Rules, 1945.

With superbug scourge looming, global group bets on biotechs to turn the tide

Gunning to beat back a global scourge of superbugs, a transatlantic group is betting tens of millions on biotech startups developing novel antibiotics.

Global cost of physical inactivity is estimated at $67.5bn a year

The worldwide economic burden of physical inactivity was at least $67.5bn (£51.5bn; €61.5bn) in 2013—equivalent to the gross domestic product of Costa Rica that year—researchers have estimated.Their...

FDA approves Sanofi’s Adlyxin for adult type 2 diabetes patients

The US Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor…

Not to be sniffed at: new antibiotics discovered in the nose

Scientists have found that a substance found in the human nose produces a previously unknown antibiotic.


Quick Search
Advertisement
 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.